Press "Enter" to skip to content

Jazz Pharma’s sleep disorder treatment gets FDA nod

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc’s treatment for patients with a form of sleep disorder, the company said on Wednesday.

Also Read:   Shield Healthcare acquires two entities for undisclosed sum